Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Ireland | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | vs
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Ireland

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | vs
    • About
      • Novartis in Ireland
      • Strategy
      • Country Leadership Team
      • Contact
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Education and Awareness
      • Patient Resources
      • Adverse Event Reporting
      • Novartis Societal Impact
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Adverse Event Reporting
      • Novartis Clinical Trials
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Environmental Sustainability
      ESG
    • News
      • News Archive
      • Stories
      • Contacts
      News
    • Careers
      • Career Search
      • Working in Novartis Ireland
      • Learning and Development
      • Early Talent
      • How We Work
      • Well-being
      • Diversity & Inclusion
      • Awards and Recognition
      Careers
    • Coronavirus
      Coronavirus
    Home

Corporate

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • Corporate
    An Interview with our Novartis Ireland Country President
  • Corporate
    Making Possible: Stepping toward a future with cell and gene therapy
  • Corporate
    Novartis utilizing manufacturing capacity to help in the fight against COVID-19
  • Corporate
    Reimagining Science in #InnovateForLife Campaign
  • Corporate
    Novartis Announces Winners of the Innovation Prize for Assistive Tech
  • Corporate
    Novartis Ireland is supporting #HoldFirm
  • Corporate
    A visual tour of scientific strategies for combating coronavirus
  • Corporate
    Novartis Ireland providing a broad range of initiatives to respond to communities impacted by COVID-19
  • Corporate
    Novartis Partnership with Trinity Centre for People with Intellectual Disabilities
  • Corporate
    Novartis opens facility for innovative cell and gene therapies in Switzerland
  • Corporate
    Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
  • Corporate
    Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE208268 May 22